Crossject is revolutionizing needle free injection


Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has seven solutions in advanced stages of development, six of which are for emergency situations.  

Zeneo illustration


Our news

Image de l'actualité

Global BSG pre-filled and injectable summit

Résumé de l'actualité

1-2 June 2023

Image de l'actualité

BIO International Convention

Résumé de l'actualité

5 - 8 June 2023


Financial news: Crossject reports financial results and business highlights for first half of 2023

Sommaire ou résumé

The company made strong progress in bringing drugs for use in emergency situations towards the market and further strengthened its financial structure to accelerate the company's development.